Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

COMP-Ang1: Therapeutic potential of an engineered Angiopoietin-1 variant

Vascular Pharmacology(2021)10.1016/j.vph.2021.106919Source: DataRank Database

COMP-Ang1: Therapeutic potential of an engineered Angiopoietin-1 variant is a research paper published in Vascular Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.67)OA: hybridTopics (24)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Keith D. Rochfort ORCID,Péter Barabás ORCID,Tim M. Curtis ORCID,Hironori Uehara ORCID,Balamurali K. Ambati ORCID

Live enrichment

PubMed:34583025 OpenAlex:https://openalex.org/W3204713700

National Institutes of Health

Grant: RO1-EY026029

Health and Social Care Services in Northern Ireland

Grant: STL/4748/13

Medical Research Council

Grant: MC_PC_15026

Science Foundation Ireland

Grant: 14/US/B3116

FWCI

0.67

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.vph.2021.106919

publisherhttps://doi.org/10.1016/j.vph.2021.106919

publisherhttps://api.elsevier.com/content/article/PII:S1537189121000914?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1537189121000914?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34583025

Fields of Study

Angiogenesis and VEGF in CancerLipid metabolism and disordersProtease and Inhibitor Mechanisms

MeSH Terms

HumansWound HealingProtein EngineeringSignal TransductionAngiopoietin-1Receptor, TIE-2Cartilage Oligomeric Matrix Protein

Keywords

AngiopoietinAngiopoietin receptorCartilage oligomeric matrix proteinAngiogenesisMedicineCancer researchIn vivoBioinformaticsPharmacologyVascular endothelial growth factorBiologyPathologyOsteoarthritisVEGF receptors

Sustainable Development Goals

SDG 0: Good health and well-being